Sugi Predict

Sugi Predict / Compounds / SCHEMBL4979464

SCHEMBL4979464

SCHEMBL4979464

CC(=O)c1ccc2cc(N3CCC(CO)CC3)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.47
▸ HRH3 Q9Y5N1 3/20 0.44
▸ CDK8 P49336 1/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ USP2 O75604 1/20 0.41
▸ GPR119 Q8TDV5 1/20 0.41
▸ RAB9A P51151 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ CYP2A6 P11509 1/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17640683 0.81 MAPT (0.52) CDK8KMT2AMEN1ALDH1A1MAPT
SCHEMBL4977907 0.80 HTR3E (0.59) ALDH1A1USP2ABL1
SCHEMBL24779093 0.80 NPC1 (0.51) CDK8KMT2AMEN1ALDH1A1MAPT
SCHEMBL4978518 0.78 ALDH1A1 (0.44) KMT2AMEN1ALDH1A1MAPTCYP2A6
SCHEMBL17631586 0.77 PRKDC (0.58) KMT2AMEN1ALDH1A1MAPTRAB9A
SCHEMBL4976412 0.76 LMNA (0.52) CDK8KMT2AMEN1ALDH1A1MAPT
SCHEMBL5145066 0.76 BRD4 (0.41) BRD4HRH3ABL1
SCHEMBL4979466 0.75 ALDH1A1 (0.40) HRH3KMT2AMEN1ALDH1A1MAPT
SCHEMBL1663654 0.75 USP2 (0.66) KMT2AMEN1ALDH1A1MAPTUSP2
SCHEMBL17640825 0.74 CYP2A6 (0.45) KMT2AMEN1ALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7341709-B2 Compositions for labeling β-amyloid plaques and neurofibrillary tangles REGENTS OF UNIVERSITY OF CALIFORNIA (US) 2008-03-11 — — US disclosed
US-20070053831-A1 Methods for binding agents to b-amyloid plaques THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2007-03-08 — — US disclosed
US-20040072371-A1 Compositions for labeling beta-amyloid plaques and neurofibrillary tangles REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE 2004-04-15 — — US disclosed
US-6660530-B2 Diagnosis of Alzheimer's disease THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-12-09 — — US disclosed
US-20020022002-A1 Methods for labeling beta-amyloid plaques and neurofibrillary tangles THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-02-21 — — US disclosed
US-6274119-B1 LABELING .BETA.-AMYLOID PLAQUES AND NEUROFIBRILLARY TANGLES IN VIVO AND IN VITRO, COMPRISES CONTACTING RADIOLABELED AMINONAPTHALENE DERIVATIVE WITH MAMMALIAN TISSUE THE REGENTS OF THE UNIV. OF CALIFORNIA 2001-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020022002-A1 Methods for labeling beta-amyloid plaques and neurofibrillary tangles OXSR1, MSR1, CBR1 BRD4 1825/4885HRH3 92/4885CDK8 3692/4885
US-20070053831-A1 Methods for binding agents to b-amyloid plaques APBA1, CLTB, FABP7 BRD4 624/4885HRH3 1301/4885CDK8 4406/4885
US-20040072371-A1 Compositions for labeling beta-amyloid plaques and neurofibrillary tangles CBR1, CBR3, MSR1 BRD4 1587/4885HRH3 185/4885CDK8 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.